12.00-12.30UPDATED CAP/IASLC/AMP MOLECULAR TESTINGGUIDELINES FOR THESELECTION OF LUNG CANCERPATIENTS FOR TREATMENTWITH TARGETED TYROSINEKINASE INHIBITORS:UPDATES, MODIFICATIONS,AND IMPLICATIONS FORCYTOLOGY SPECIMENSPaul VanderLaan, MD, PhD,Department of Pathology, BethIsrael Deaconess Medical Center,Boston, Massachusetts, USA

12.30-13.30 LUNCH

VII SESSIONUPDATES IN MODERNCYTOPATHOLOGY (II)

ChairsPietro Micheli, MD, Ospedaledei Colli, Naples, ItalyRoberto Bianco, MD, PhDUniversity of Naples Federico II,Italy

13.30-14.00LIQUID BIOPSY:STATE OF ARTUmberto Malapelle, PhD,University of Naples Federico II,Italy

14.00-14.30DETECTION OF ALK ANDROS1 POSITIVE NSCLC BYIMMUNOCYTOCHEMISTRY ONCONVENTIONAL CYTOLOGY

Spasenija Savic, MD, UniversityHospital Basel, Switzerland

14.30-15.00APPLICATION OF NANOSTRING TECHNOLOGY ON CYTOLOGICAL SPECIMENRossella Bruno, MD, University of Pisa School of Medicine, Pisa, Italy

15.00-15.30SALVAGING THE SUPERNATANT:NEXT GENERATIONCYTOPATHOLOGY FOR SOLIDTUMOR MUTATION PROFILINGSinchita Roy-Chowdhuri, MD,PhD, MD Anderson Cancer Center,Houston, TX, USA

15.30-16.00PD-L1 TESTING: ISSUES FROMROUTINE PRACTICEElena Vigliar, MD, PhD, Universityof Naples Federico II, Italy

16.00-16.30BEYOND PD-L1 TESTINGMaría D. Lozano Escario, MD, Phd,University of Navarra Clinic,Pamplona, Spain

16.30-17.00TAKE HOME-MESSAGESGiancarlo Troncone, MD, PhD,University of Naples Federico II, Italy

con il patrocinio di

26-27 November 2018Naples, Italy Centro Congressi Federico IIVia Partenope, 36 Napoli

Meeting Director Giancarlo Troncone

Honorary PresidentsLucio PalombiniAntonio VetraniDipartimento di Sanità PubblicaDirettore Maria Triassi

Università degli Studi di Napoli Federico II

Segreteria scientificaClaudio Bellevicine, Umberto Malapelle,Elena Vigliar

concerto srlCalata San Marco, 13 80133 Napolitel. +39 081 19569195 fax +39 081 19030044info@concertosrl.net www.concertosrl.net

Obiettivo formativoContenuti tecnico-professionali (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica. Malattie rare.

Evento ECM n. 700- 229869 ed. 112 crediti formativi ECM per:Medico Chirurgo (genetica medica; oncologia;anatomia patologica; biochimica clinica; endocrinologia;malattie metaboliche e diabetologia; medicina interna;chirurgia generale; chirurgia toracica; radiodiagnostica; radioterapia; ginecologia e ostetricia; urologia; anestesia e rianimazione; laboratorio di genetica medica),Biologo, Tecnico Sanitario Laboratorio Biomedico

Ai fini dell’attribuzione dei crediti ECM, è necessario procedere alla compilazione dei questionari di verifica e valutazione esclusiva-mente in modalità ONLINE.Il questionario sarà disponibile sulla piattaforma dalla conclu-sione del congresso e a disposizione dei partecipante della ricezione della mail.Resterà attivo per soli 3 giorni e sarà possibile effettuare un solo tentativo per la compilazione.

Quota di partecipazione:Euro 50,00 + IVA 22% (€ 61,00 )La quota d’iscrizione da diritto alla partecipazione ai lavori, ai coffe break, ai lunch, all’attestato di partecipazione e ai crediti ECM per gli aventi diritto.

È prevista traduzione simultanea dall’inglese.

Segreteria Organizzativa e Provider ECM

Amgen Arrow Diagnostics AstraZeneca BiocartisBoehringer-Ingelheim ItaliaHologic Italia Leica Biosystems

Merck Serono MSD ItaliaPfizer RocheSialThermoFisher

Si ringraziano:

26 NOVEMBER

9.30WelcomeMaria TriassiDirettore Dipartimento SanitàPubblicaMauro TruiniPresidente SIAPEC-IAPGaetano De RosaPast President SIAPEC-IAPLucio PalombiniProfessore EmeritoGiancarlo TronconeMeeting Director

10.00-10.30OPENING LECTURELucio Palombini MD, Universityof Naples Federico II, Italy

I SESSIONCLASSIFICATION INCYTOPATHOLOGY (I)ChairsEsther Diana Rossi, MD, CatholicUniversity of Rome, ItalyStefania Staibano, MD, PhDUniversity of Naples Federico II,Italy

10.30-11.00WHY DO YOU NEED TOGIVE NAMES?Fernando Schmitt, MD, PhD, FIAC, Porto University and IPATIMUP, Porto, Portugal

11.00-11.30THE MILAN SYSTEM FORREPORTING SALIVARY GLANDCYTOPATHOLOGYPhilippe Vielh, MD, PhD, FIAC,Laboratoire National de Santé,Dudelange, Luxembourg

11.30-12.00 COFFEE BREAK

II SESSIONCLASSIFICATION INCYTOPATHOLOGY (II)ChairsGerardo Botti, MD, IstitutoPascale, Napoli, ItalyPio Zeppa, MD, PhD, Universityof Salerno, Italy

12.00-12.30THE PARIS SYSTEMFOR REPORTING URINARYTRACT CYTOLOGYAshish Chandra, MD, FRCPath,DipRCPath, Guy’s and St. Thomas Hospital NHS, Foundation Trust, London

12.30-13.00THE YOKOHAMA SYSTEMFOR REPORTING DIRECTLYSAMPLED ENDOMETRIALCYTOLOGY: THE QUEST TODEVELOP A STANDARDIZEDTERMINOLOGYFranco Fulciniti, MD, PhD,Clinical Cytopathology Service,Istituto Cantonale di Patologia,Locarno Switzerland

13.00-14.00 LUNCH

III SESSIONCLASSIFICATION INCYTOPATHOLOGY (III):FOCUS ON THYROIDChairsGuido Fadda, MD, CatholicUniversity of Rome, Italy

14.00-14.30THYROID FNA: NEWCLASSIFICATIONS AND NEWINTERPRETATIONSBeatrix Cochand-Priollet, MD,PhD, Department of Pathology,Cochin Hospital, University Paris-Descartes, Paris, France

14.30-15.00PERFORMANCE QUALITYMEASURES IN THYROIDCYTOPATHOLOGY: ARE WEGOOD IN APPLYING BETHESDACRITERIA?Paul VanderLaan, MD, PhD,Department of Pathology, BethIsrael Deaconess Medical Center,Boston, Massachusetts, USA

15.00-15.30MOLECULAR PATHOLOGYOF THYROID TUMOURS OFFOLLICULAR CELLS:GENETIC ALTERATIONS ANDTHEIR CLINICOPATHOLOGICALRELEVANCEGiovanni Tallini, MD,University of Bologna, Italy

15.30-16.00 COFFEE BREAK

IV SESSIONTHYROID MOLECULARCYTOPATHOLOGY:AN ITALIAN EXPERIENCEChairsGiancarlo Troncone, MD,PhD, University of NaplesFederico II, ItalyAnnamaria Colao, MD,PhD University of NaplesFederico II, Italy

16.00-16.30THE TIRNET PROJECTClaudio Bellevicine, MD, PhD,University of Naples Federico II,Italy

TIRNET Group InteractiveDiscussion

16.30-17.30THE BETHESDA SYSTEMFOR REPORTING THYROIDCYTOPATHOLOGY EXPLAINED.FREQUENTLY ASKEDQUESTIONS FROMNON-PATHOLOGISTMassimo Bongiovanni, MD,University Institute of Pathology,UNIL-CHUV, Lausanne, SwitzerlandClaudio Bellevicine, MD, PhD,University of Naples Federico II,Italy

THE TIRNET Group DiscussantL. Barba, G. Bellastella, B. Biondi,M. Cacciapuoti, A. Caleo,S. Campione, M. G. Chiofalo,G. Ciancia, G. Conzo, I. Cozzolino,M. D’ Anna, R. D’Anna, G. De Chiara, G. De Dominicis, N. De Rosa, S. Di Martino, F. Di Gennaro, G. Docimo,F. Fonderico, D. Gerbasio, R. Giannattasio, G. Iannaci, E. M. Iervolino, S. Iorio,F. La Vecchia, C. A. Leone,F. Lo Calzo, N.S. Losito, G. Lupoli,V. Marotta, M. Mascolo, S. Masone,R. Monaco, V. Novizio, V. Nuzzo,L. Pezzullo, C. Peirce, G. Pontieri,D. Salvatore, F. Scavuzzo,D. Serino, A. A. Sinisi,S. Spiezia, E. Vigliar, P. Zeppa

18.00CLOSING REMARKSGiancarlo Troncone, MD, PhD,University of Naples Federico II,Italy

27 NOVEMBER

10.00V SESSIONUPDATES IN MODERNCYTOPATHOLOGY (I)ChairsPhilippe Vielh, MD, PhD, FIAC,Laboratoire National de Santé,Dudelange, LuxembourgFiamma Buttitta, MD, PhD,University of Chieti, Italy

10.00-10.30ROADMAP TOWARD THEDEVELOPMENT OF A NETWORKOF ITALIAN LABORATORIESPERFORMING NEXTGENERATION SEQUENCINGAntonio Marchetti, MD, PhD,University of Chieti, Italy

10.30-11.00ISSUES IN MOLECULARCYTOPATHOLOGY:AN OVERVIEWGiancarlo Troncone, MD, PhDUniversity of Naples Federico II,Italy

11.00-11.30 COFFEE BREAK

VI SESSIONGUIDELINES UPDATES INMODERN CYTOPATHOLOGYChairsGiancarlo Troncone, MD, PhD,University of Naples Federico II, ItalyGiovanni Tallini, MD, University ofBologna, Italy

11.30-12.00COLLECTION AND HANDLINGOF THORACIC SMALL BIOPSYAND CYTOLOGY SPECIMENSFOR ANCILLARY STUDIES:GUIDELINE FROM THE COLLEGEOF AMERICAN PATHOLOGISTSSinchita Roy-Chowdhuri, MD,PhD, MD Anderson Cancer Center,Houston, TX, USA